You can buy the new trolley for about £4.80 from your local supermarket or online.
But it can cost up to £7,500.
The new trolley is the first of its kind and will be rolled out across the country.
It will be fitted with a mobile medical treatment system.
The device allows people to treat themselves using a tube that is attached to a computer.
The new system allows people with severe or chronic medical conditions to treat their condition in a matter of minutes, saving lives and money.
The company behind the device, Aventis Pharmaceuticals, said it was an ideal treatment for people with kidney disease.
Its new technology is designed to allow people with chronic kidney disease to be treated at home with less expensive and less invasive treatments.
The first patient to get the device will be treated in the UK next month.
Aventis said its trolley will be a first for a medical treatment product in the world.
The Trolley – an online and offline system, which is currently in beta – will allow people to use a mobile device for their medical treatment.
It can be fitted into a car, tablet or phone and will also be available in the future for the NHS.
The trolley system was developed by the company Aventes Pharmaceuticals and is currently being trialled in the United Kingdom.
The technology will be sold online and in shops across the UK.
The system is designed for people to get their first prescription by emailing their doctor or a healthcare provider with a copy of a doctor’s prescription and a photo.
It is designed so people can start by simply getting the device and then using it to visit their GP, doctor of optometry or specialist medical provider.
For people with renal disease, the system will allow them to access the same treatments as those prescribed for people without kidney disease or chronic kidney failure.
The devices are being developed by a group of doctors at the Royal Free Hospital in London, who have been working together for the past five years.
They have developed the device for people who suffer from chronic kidney or kidney failure and the company is looking to bring it to the UK, but the first patients to receive it will be in the next few weeks.
They are now looking to have the device available by Christmas and will roll it out across Britain in early 2019.
“We are very excited about the technology and its potential to revolutionise healthcare for people in the most deprived areas of the country,” said Dr Sarah Wilson, director of health and wellbeing at Aventas Pharmaceuticals.
“The technology is being developed to treat people with a variety of medical conditions and we believe it can help to improve lives for people living with chronic disease.”
We will work closely with NHS England and the Royal College of GPs to ensure we are making the best use of the technology so it is available for everyone in the country.
“The trolle is similar to the device that was developed at University College London (UCL) but is much smaller and less expensive.
The NHS said it wanted to see a trial of the new technology before the trolley goes into use.”
This is an innovative technology that has the potential to make a huge difference to the lives of millions of people in our communities, but more work needs to be done to prove the technology works in real-world conditions,” a spokesman said.”
If it does, we will introduce it into clinical trials in the near future.
“The UK government is working with a number of healthcare providers to make sure that all the necessary tests and procedures are carried out to make the new system work.
Aventas said the technology will help people with milder forms of chronic kidney, liver or bladder disease, as well as chronic pain and depression, to manage their illness.
It will also help people who have kidney disease, who can’t afford the expensive and invasive treatments available elsewhere, and people with high cholesterol, diabetes or heart disease.
People with kidney failure will be able to access a trolley with the latest tests and medicines available.
People who have severe or advanced kidney disease will be better able to receive the latest treatments.
And people with the most severe forms of diabetes and high blood pressure will have access to the most advanced treatments.
Dr Wilson said the trollet could be a significant advance for people suffering from chronic diseases.
We hope the technology becomes widely available as a way of saving lives, particularly those with chronic diseases, and it will bring the best value to people suffering with kidney and liver disease.
We have the technology to provide the best care, and we will continue to work with the medical and care system to deliver this technology in an accessible and affordable way,” she said.
In the UK the government has pledged to introduce a universal basic income to provide every person in the nation with £100 a week.
This would be paid